It was also shown that the ILC2 cytokines, IL-5, and GM-CSF could control tumor growth-as genetic ablation of IL-5 and GM-CSF increased the tumor burden in the murine CRC model [257]. The gene discussed is IL5; the disease is colorectal carcinoma.